Current Study: O 9

Study: O 9

Investigator: Thomas Marbury, MD
Research Study: Liver Studies

• To determine how the investigational drug is broken down and removed from the body in female volunteers with liver impairment when compared to volunteers with normal liver function
• Information regarding safety and side effects that may occur will also be collected
• This study is for research purposes only and is not intended to treat your liver disease

Method of Administration:
Single oral dose of study drug, given as 2 tablets

Thomas Marbury, MD

To qualify:
• Female
• 18 to 75 years old
• Must have decreased liver function or disease such as fatty liver disease (NASH), Hepatitis C, past history of alcohol related liver disease or cirrhosis
• Volunteers may be taking medicines such as spironolactone (Aldactone®), furosemide (Lasix®), lactulose, or rifaximin (Xifaxan®)
• May also have ascites (fluid in your abdomen) or encephalopathy (brain condition that causes irritability or trouble sleeping)

• 1 eligibility screening visit
• 7 days and 6 nights in our research facility
• 1 end of study follow-up visit

Qualified female participants will be compensated up to $1,825 for time and travel
Qualified female participants will receive study medication, study related physical exams

5055 South Orange Avenue, Orlando, FL 32809

Orlando Clinical Research Center
5055 South Orange Avenue
Orlando, FL 32809

Recruiting Number: 407.240.7878

Apply now for Study: O 9